| Concentration | Model 1a | Model 2b | Model 3c | ||||||
---|---|---|---|---|---|---|---|---|---|---|
β | 95 % CI | P-valued | β | 95 % CI | P-valued | β | 95 % CI | P-valued | ||
F2-Isoprostanes (ng/ml) | <0.049 | Reference | - | - | Reference | - | - | Reference | - | - |
0.049–< 0.066 | 2.78 | −3.68, 9.24 | 0.40 | 4.65 | −2.89, 12.2 | 0.23 | 4.61 | −2.74, 11.9 | 0.22 | |
0.066–< 0.086 | 4.41 | −2.05, 10.9 | 0.18 | 7.60 | 0.01, 15.2 | 0.050 | 7.31 | −0.10, 14.7 | 0.05 | |
≥0.086 | 6.18 | −0.28, 12.6 | 0.06 | 9.82 | 1.78, 17.9 | 0.02 | 7.47 | −0.58, 15.5 | 0.07 | |
Isofurans (ng/ml) | <0.26 | Reference | - | - | Reference | - | - | Reference | - | - |
0.26–< 0.44 | 10.46 | 4.24, 16.7 | 0.001 | 8.17 | 1.29, 15.0 | 0.02 | 7.33 | 0.55, 14.1 | 0.03 | |
0.44–< 0.79 | 5.79 | −0.44, 12.0 | 0.07 | 5.05 | −2.18, 12.3 | 0.17 | 5.49 | −1.62, 12.6 | 0.13 | |
≥0.79 | 11.5 | 5.36, 17.7 | <0.001 | 16.4 | 9.10, 23.7 | <0.001 | 14.9 | 7.70, 22.2 | <0.001 |